ALL MEDICAL AESTHETICS LIMITED
Opportunity 70/100 (strong), bankability 70/100. Share purchase looks the cleaner deal structure. Most likely exit: distressed disposal / insolvency (65/100).
Data confidence
Overall: medium (76/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Signals from accounts
Derived from iXBRL accounts · accounting standard not declaredKey financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · accounting standard unknown| Metric | 2025-05-31 | 2024-05-31 |
|---|---|---|
| Total assets | £4.7k | £1.0k |
| Current assets | £10.9k | £4.5k |
| Cash | £8.4k | £1.5k |
| Debtors | — | £479 |
| Net assets | £-20.4k | £-26.0k |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 1 confirmation-statement
- • 1 confirmation-statement
- • 1 accounts
Corporate timeline (7 events)Click to expand
- 2026-02-02📄accounts-with-accounts-type-unaudited-abridgedaccounts · AA
- 2025-01-17📄accounts-with-accounts-type-unaudited-abridgedaccounts · AA
- 2023-11-24📄accounts-with-accounts-type-unaudited-abridgedaccounts · AA
- 2022-05-01🏢Company incorporatedAs ALL MEDICAL AESTHETICS LIMITED
- 2022-05-01➕DAVIES, James Richard, Dr appointeddirector
- 2022-05-01➕LOVETT, Amy Lisa, Dr appointeddirector
- 2022-05-01📄incorporation-companyincorporation · NEWINC
Owner dependency
Some founder dependency, but not acute. A structured handover period should cover most risk.
- +Two-director setup: Only two active directors — typical of owner-managed SMEs but limits succession.
Succession & seller-readiness
Limited succession signal. Not a near-term off-market candidate.
- secondaryTwo-director governance: Small-team governance. Succession depth is thin but not absent.
Red flags
cleanShareholders & ownership
2 active beneficial owners| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Dr James Richard Davies Individual · British · DOB 11/1993 · age 33 | 25–50% | 25–50% | board control25-50% shares · 25-50% voting · board control | 01/05/2022 |
Dr Amy Lisa Lovett Individual · British · DOB 09/1994 · age 32 | 25–50% | 25–50% | board control25-50% shares · 25-50% voting · board control | 01/05/2022 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Trade services · HR postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| A&M CONVENIENCE STORES LTD→ 16120072 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| ACT ABRASIVES LIMITED→ 15015843 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| AGRICROWN BIOTECH CO., LIMITED→ 10335031 · est 2016 · no financials extracted | — | — | — | — | 9y | — | — |
| AISHANGMETPINS CRAFTS CO., LTD→ 15810696 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| ALETHEIA SECURITY AND INVESTIGATIONS LTD→ 16414434 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| AMBREY (MARKAB) LIMITED→ 10923321 · est 2017 · no financials extracted | — | — | — | — | 8y | — | — |
| AMBREY (MENKAR) LIMITED→ 10755206 · est 2017 · no financials extracted | — | — | — | — | 8y | — | — |
| AMBREY 25N LIMITED→ 10808706 · est 2017 · no financials extracted | — | — | — | — | 8y | — | — |
| AMBREY ATHENA LIMITED→ 12710556 · est 2020 · no financials extracted | — | — | — | — | 5y | — | — |
| AMBREY GLOBAL RESPONSE (NO.2) LIMITED→ 16361839 · est 2025 · no financials extracted | — | — | — | — | 1y | — | — |
| AMBREY GLOBAL RESPONSE (NO.3) LIMITED→ 16353152 · est 2025 · no financials extracted | — | — | — | — | 1y | — | — |
| AMBREY GLOBAL RESPONSE LTD→ 16143286 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (2 active · 0 resigned)
Click a director name to see their full track record across all companies.